The 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023)

Dear colleagues,

We are pleased to announce the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023), which will be held from 16–30 March 2023.

The opportunities for new therapeutic targets have expanded tremendously. In recent years, cancer genomics has expanded our view of cancer vulnerabilities, new technologies have changed the paradigm of what can be successfully targeted, and new immunotherapy targets are emerging rapidly. This conference aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. It will bring together experts in basic, translational, and clinical research to discuss the current research and the opportunities as well as obstacles that lie ahead in the field.

The focus of this conference is the translation of recent discoveries into new therapeutic targets for cancer therapies. Topics of interest include, but are not limited to, the following:

• Translational cancer genomics and epigenomics.
• Emerging immunotherapy targets.
• Overcoming therapeutic hurdles in resistance and undruggable proteins

Abstract Submission - 18th November 2022

Acceptance Notification - 12th December 2022

File Submission - 16th January 2023

The conference is free of charge.